Exagen Inc. (XGN) Stock Forecast
Data as of Aug 5, 2026Healthcare · Current price $6.45 (+37.82%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
XGN vs Sector & Market
| Metric | XGN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +87.4% | +16316.1% | +17.1% |
| P/E Ratio | -2.95 | 3.33 | 36.31 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $71M | $71M | $72M | 5 |
| 2027-12-31 | $78M | $81M | $86M | 5 |
| 2028-12-31 | $89M | $91M | $93M | 2 |
| 2029-12-31 | $100M | $101M | $104M | 1 |
| 2030-12-31 | $105M | $107M | $110M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.88 | $-0.69 | $-0.38 | 3 |
| 2027-12-31 | $-0.44 | $-0.44 | $-0.42 | 3 |
| 2028-12-31 | $-0.16 | $-0.15 | $-0.15 | 1 |
| 2029-12-31 | $0.05 | $0.06 | $0.06 | 1 |
| 2030-12-31 | $0.04 | $0.04 | $0.04 | 1 |
Frequently Asked Questions
What is the analyst consensus for XGN?
The consensus among 8 analysts covering Exagen Inc. (XGN) is Buy with an average price target of $8.67.
What is the highest price target for XGN?
The highest analyst price target for XGN is $10.00.
What is the lowest price target for XGN?
The lowest analyst price target for XGN is $8.00.
How many analysts cover XGN?
8 analysts have issued ratings for Exagen Inc. in the past 12 months.
Is XGN a buy or sell right now?
Based on 8 analyst ratings, XGN has a consensus rating of Buy (2.00/5) with a +87.4% upside to the consensus target of $8.67.
What are the earnings estimates for XGN?
Analysts estimate XGN will report EPS of $-0.69 for the period ending 2026-12-31, with revenue estimated at $71M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.